RetroSense Therapeutics Announces Exclusive Option to Intellectual Property Covering Vision Augmentation From Massachusetts General Hospital
3/27/2013 10:53:53 AM
More...
|
RetroSense Therapeutics Announces Notice of Allowance for New U.S. Patent Application Broadly Covering Optogenetic Approaches to Vision Restoration
3/5/2013 9:31:22 AM
More...
|
RetroSense Therapeutics Welcomes Dr. Steven Bramer as Chief Development Officer
10/4/2012 10:19:18 AM
More...
|
RetroSense Therapeutics Completes pre-IND Meeting for RST-001
5/24/2012 10:15:50 AM
More...
|
RetroSense Therapeutics Welcomes Dr. Peter Francis as Clinical Director
4/19/2012 10:00:39 AM
More...
|
Foundation Fighting Blindness Grants RetroSense Therapeutics $250,000 for Research into Using Genes from Algae to Reverse Severe Vision Loss
2/10/2012 2:03:54 PM
More...
|
RetroSense Therapeutics Announces License Agreement With Wayne State University for Breakthrough Approaches to Vision Restoration
10/19/2011 5:53:40 AM
More...
|